AVALO THERAPEUTICS, INC. Conversion of Stock, Shares Issued
AVALO THERAPEUTICS, INC. (AVTX) reported Conversion of Stock, Shares Issued of 4.66 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2026-08-06
- AVALO THERAPEUTICS, INC. conversion of stock, shares issued for the quarter ending 2026-06-30 was 4.66M shares.
- AVALO THERAPEUTICS, INC. conversion of stock, shares issued for the quarter ending 2026-03-31 was 5.76M shares.
- AVALO THERAPEUTICS, INC. conversion of stock, shares issued for fiscal 2025 was 6.10M shares.
| Period end | Conversion of Stock, Shares Issued 3 month | Conversion of Stock, Shares Issued 6 month | Conversion of Stock, Shares Issued 12 month |
|---|---|---|---|
| 2026-06-30 | 4.66M shares 10-Q · filed 2026-08-06 | 10.41M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 5.76M shares 10-Q · filed 2026-05-13 | ||
| 2025-12-31 | 6.10M shares 10-K · filed 2026-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |